Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01102257 · ClinicalTrials.gov registry record · Phase 2
Dry Eye Assessment and Management: Feasibility Study
A Phase 2 study of Dry Eye Syndromes and Keratoconjunctivitis Sicca, sponsored by Asbell, Penny, M.D..
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT01102257 is a Phase 2 study of Dry Eye Syndromes and Keratoconjunctivitis Sicca that has completed, run by Asbell, Penny, M.D.. The registered enrollment target is 23 participants, below the 413-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01102257, a Phase 2 study of Dry Eye Syndromes and Keratoconjunctivitis Sicca, has completed, sponsored by Asbell, Penny, M.D..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a protocol investigating the efficacy of omega-3 fatty acids in treating dry eye disease. The study is termed "feasibility" because its purpose is to demonstrate an ability to execute the proposed protocol with compliance at two sites rather than generate statistically relevant data concerning the safety and efficacy of the supplement in patients with dry eye disease.
Conditions Studied
Interventions
- DRUG Olive Oil
- DRUG Omega-3 EFA Supplement
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01102257
The ClinicalTrials.gov registry entry for NCT01102257 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 413-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (94% lower). The listed sponsor is Asbell, Penny, M.D., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dry Eye Syndromes appearing as the primary indexed condition, and to 2 interventions - of which Olive Oil is the first listed.
NCT01102257 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01102257 about?
NCT01102257 is a clinical study titled "Dry Eye Assessment and Management: Feasibility Study". The purpose of this study is to test a protocol investigating the efficacy of omega-3 fatty acids in treating dry eye disease. The study is termed "feasibility" because its purpose is to demonstrate an ability to execute the proposed protocol with compliance at two sites rather than generate statist...
What is the current status of trial NCT01102257?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2010-01. Estimated completion is 2011-03.
What conditions does trial NCT01102257 study?
This clinical trial studies the following conditions: Dry Eye Syndromes, Keratoconjunctivitis Sicca.
What interventions are being tested in trial NCT01102257?
The interventions under investigation include: Olive Oil (DRUG), Omega-3 EFA Supplement (DRUG).
Who is sponsoring clinical trial NCT01102257?
This trial is sponsored by Asbell, Penny, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01102257 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
COMPLETED · Phase 2
-
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
COMPLETED · Phase 2
-
CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)
COMPLETED · Phase 2
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.
COMPLETED · Phase 2
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.